Abstract |
The p-[N,N-bis(2-chloroethyl)amino] phenylacetic acid esters of hecogenin and aza-homo- hecogenin have been prepared and their antineoplastic activity was evaluated against two basic drug screening systems in rodents, P388 lymphocytic and L1210 lymphoid murine leukemias. Among the compounds tested, the p-[N,N-bis(2-chloroethyl)amino] phenylacetic acid ester of aza-homo- hecogenin was appeared to possess a significant higher antileukemic effect. These results support that the alkylating esters of hecogenin produce important antitumor activity as well as, indicate that the aza-homo- hecogenin ester exhibits significantly higher activity due to lactam group (-NHCO-) modification.
|
Authors | Charalambos Camoutsis, Dimitrios Trafalis, George Pairas, Athanasios Papageorgiou |
Journal | Farmaco (Societa chimica italiana : 1989)
(Farmaco)
Vol. 60
Issue 10
Pg. 826-9
(Oct 2005)
ISSN: 0014-827X [Print] France |
PMID | 16139280
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Azasteroids
- Phenylacetates
- Sapogenins
- hecogenin
|
Topics |
- Animals
- Antineoplastic Agents
(chemistry, pharmacology, therapeutic use)
- Azasteroids
(chemistry, pharmacology, therapeutic use)
- Drug Screening Assays, Antitumor
- Leukemia L1210
(drug therapy)
- Leukemia P388
(drug therapy)
- Mice
- Molecular Structure
- Phenylacetates
(chemistry, pharmacology, therapeutic use)
- Sapogenins
(chemistry, pharmacology, therapeutic use)
- Structure-Activity Relationship
|